0000950170-24-033589.txt : 20240319
0000950170-24-033589.hdr.sgml : 20240319
20240319164650
ACCESSION NUMBER: 0000950170-24-033589
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240315
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Conley Emily
CENTRAL INDEX KEY: 0001907812
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40671
FILM NUMBER: 24764170
MAIL ADDRESS:
STREET 1: C/O NUVALENT, INC.
STREET 2: ONE BROADWAY 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvalent, Inc.
CENTRAL INDEX KEY: 0001861560
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 508-446-2272
MAIL ADDRESS:
STREET 1: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
ownership.xml
4
X0508
4
2024-03-15
0001861560
Nuvalent, Inc.
NUVL
0001907812
Conley Emily
C/O NUVALENT, INC.
ONE BROADWAY, 14TH FLOOR
CAMBRIDGE
MA
02142
true
false
false
false
true
Class A Common Stock
2024-03-15
4
M
false
13333
9.36
A
13341
D
Class A Common Stock
2024-03-15
4
S
false
2127
79.81
D
11214
D
Class A Common Stock
2024-03-15
4
S
false
7685
80.63
D
3529
D
Class A Common Stock
2024-03-15
4
S
false
2321
81.25
D
1208
D
Class A Common Stock
2024-03-15
4
S
false
200
82.32
D
1008
D
Class A Common Stock
2024-03-15
4
S
false
1000
84.44
D
8
D
Stock Option (Right to Buy)
9.36
2024-03-15
4
M
false
13333
0
D
2032-06-16
Class A Common Stock
13333
6667
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.12 to $80.08, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) of this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.13 to $81.12, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.13 to $81.83, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.23 to $82.36, inclusive.
This option is fully vested and exercisable.
/s/ Deborah Ann Miller, attorney-in-fact
2024-03-19